Benefit–risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases

MS Kostapanos, CV Rizos, MS Elisaf - Drug safety, 2014 - Springer
Rosuvastatin has been marketed for approximately a decade. In this review we critically
discuss available evidence on the benefits and risks from its use. In clinical trials using …
被引用次数：15 相关文章

Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases

MS Kostapanos, CV Rizos, MS Elisaf - Drug safety, 2014 - pubmed.ncbi.nlm.nih.gov
Rosuvastatin has been marketed for approximately a decade. In this review we critically
discuss available evidence on the benefits and risks from its use. In clinical trials using …

Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases

MS Kostapanos, CV Rizos, MS Elisaf - Drug Safety, 2014 - infona.pl
Rosuvastatin has been marketed for approximately a decade. In this review we critically
discuss available evidence on the benefits and risks from its use. In clinical trials using …

[引用][C] Benefit-Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases

MS KOSTAPANOS, CV RIZOS, MS ELISAF - Drug safety, 2014 - pascal-francis.inist.fr
Benefit-Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related
Diseases CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases …

Benefit-Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases

MS Kostapanos, CV Rizos, MS Elisaf - Drug Safety, 2014 - search.proquest.com
Rosuvastatin has been marketed for approximately a decade. In this review, the authors
critically discuss available evidence on the benefits and risks from its use. In clinical trials …

Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.

MS Kostapanos, CV Rizos, MS Elisaf - Drug Safety, 2014 - europepmc.org
Rosuvastatin has been marketed for approximately a decade. In this review we critically
discuss available evidence on the benefits and risks from its use. In clinical trials using …

[引用][C] Benefit-Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases

MS KOSTAPANOS, CV RIZOS, MS ELISAF - Drug safety, 2014 - Adis International

[引用][C] Benefit–Risk Assessment of Rosuvastatin in the Treatment of Atherosclerosis and Related Diseases

MS Kostapanos, CV Rizos, MS Elisaf - Drug safety, 2014 - Adis International